Leading science, pioneering therapies

CRM Publications

Found 6 results
Filters: Keyword is Neuroprotective Agents  [Clear All Filters]
2015
Vesterinen HM, Connick P, Irvine CMJ, Sena ES, Egan KJ, Carmichael GG, Tariq A, Pavitt S, Chataway J, Macleod MR et al..  2015.  Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.PLoS One. 10(4):e0117705.
2012
Franklin RJM, ffrench-Constant C, Edgar JM, Smith KJ.  2012.  Neuroprotection and repair in multiple sclerosis.Nat Rev Neurol. 8(11):624-34.
2011
Bell KF, Al-Mubarak B, Fowler JH, Baxter PS, Gupta K, Tsujita T, Chowdhry S, Patani R, Chandran S, Horsburgh K et al..  2011.  Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning.Proc Natl Acad Sci U S A. 108(1):E1-2;authorreplyE3-4.
2006
Majed HH, Chandran S, Niclou SP, Nicholas RS, Wilkins A, Wing MG, Rhodes KE, Spillantini MGrazia, Compston A.  2006.  A novel role for Sema3A in neuroprotection from injury mediated by activated microglia.J Neurosci. 26(6):1730-8.
2002
Golde S, Chandran S, Brown GC, Compston A.  2002.  Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression.J Neurochem. 82(2):269-82.